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Background The use of adenosine is sometimes considered as a limiting
factor for of fractional flow reserve (FFR) measurements. The present study
sought to quantify the potential of contrast medium (CM) to induce microvascular
dilatation as assessed by the changes in Doppler flow velocity measurements.
Methods In 30 patients, Doppler-derived flow velocity measurements were
obtained in 10 right coronary arteries (RCA) and 20 left coronary arteries (LCA)
free of significant stenosis. Flow velocity was measured at baseline and after
8mL intracoronary (IC) bolus administrations of arterial blood at body tempera-
ture, saline and CM compared to intracoronary boluses of adenosine at room tem-
perature. The hyperemic value was expressed in percent of the maximum flow
velocity reached in a given artery (Q/Qmax, %). To translate the IC adenosine dose
into its effect on FFR, a model based on standard coronary physiology linked the
degree of hyperemia to the relative distal coronary pressure (Pd/Pa). 
Results Doppler flow velocity varied among 8mL IC boluses of arterial
blood, saline and contrast (p<0.001), and all pairwise comparisons were sig-
nificant (p<0.001 for blood and contrast; p=0.041 for saline and blood; and
p=0.013 for saline and contrast). Hyperemic response after injection of 8mL
of CM reached 59±17% of that achieved maximum hyperemia. While Base-
line, arterial blood and saline achieved respectively 38±12%, 45±14% and
51±14% of Q/Qmax. The incidence of transient atrio ventricular blocks was
38% after injection of 200 μg, while it was not observed withcm. According
to our theoretical model, whencm reach 59±17% of that achieved maximum
hyperemia after adenosine in Doppler flow velocity it correspond to a Pd/Pa
ratio of 0.85, where FFR is 0.79 and the resting Pd/Pa is 0.90. 
Conclusion CM reaches approximately 60% of the maximal flow velocity
as compared to Adenosine IC. This corresponds to a difference of only 6%
when “translated” in terms of FFR.
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Introduction Assessment of the functional significance of left anterior
descending coronary artery (LAD) stenosis of intermediate severity (IS) is
challenging. A direct comparison of fractional flow reserve (FFR), instanta-
neous wave-free ratio (IFR), and non-invasive coronary flow reserve (CFR)
has never been performed. Our objective was to test the usefulness of non-
invasive CFR by comparison to invasive FFR and IFR in patients with LAD
stenosis of angiographic IS and stable coronary artery disease. 
Methods 58 stable consecutive patients (mean age, 68±10 years; with
angiographic proximal or mid LAD stenosis of IS (40-70% diameter stenosis
on quantitative coronary angiography), no previous anterior myocardial infarc-
tion, were prospectively studied. They underwent iFR which was calculated as
a trans-lesion pressure ratio during a specific period of baseline diastole, FFR
with intracoronary bolus adenosine (150μg), and CFR using intravenous ade-
nosine (140μg/kg/min over 2min) in the distal part of the LAD, the same day.
CFR was defined as hyperemic peak diastolic LAD flow velocity divided by
baseline flow velocity, and FFR was defined as distal pressure divided by
mean aortic pressure during maximal hyperemia. 
Results The mean values of iFR, FFR, and CFR were 0.88±0.07,
0.81±0.08, and 2.4±0.6 respectively. A significant correlation was found
between CFR and FFR (r=0.72, curvilinear relationship), FFR and IFR
(r=0.63, linear relationship), and between CFR and IFR (r=0.44) (all, p<0.01).
Using a ROC curve analysis, the best cut-off to detect a significant lesion
based on FFR assessment (FFR <0.8, n=16) was iFR ≤0.86 with a sensitivity
(Se) of 75%, specificity (Sp) of 81%, AUC 0.8±0.05; and CFR ≤2 with a Se
of 82%, Sp of 85%, AUC 0.9±0.03, (all, p<0.001). Based on these cut-offs,
discordant results between CFR and FFR were observed in 9 cases (accuracy
84%), between CFR and iFR in 14 cases (accuracy 76%), and between iFR
and FFR in 11 cases (accuracy 81%).
Conclusion In stable patients with LAD stenosis of IS, non-invasive CFR
is a useful tool to detect a significant lesion based on FFR. Furthermore, CFR
is better correlated to FFR than to iFR, and its accuracy seems as good as iFR
in this setting.
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Purpose To evaluate the safety of extended-delay stenting (>7 days
between procedures) in the setting of percutaneous coronary intervention
(PCI) for acute ST-segment elevation myocardial infarction (STEMI).
Methods This ongoing prospective observational study is being conducted
in STEMI patients with a high thrombus burden in the infarct-related artery
(IRA). Patients are enrolled if the operator decides to try to restore the best
TIMI flow with the thinnest tool and defer stent implantation for >7 days
under optimal anticoagulation to reduce thrombus burden. The primary end-
point is the composite of reocclusion of the IRA or sudden death between the
two procedures, and deterioration of the flow (from the final flow achieved
after the first procedure to the initial flow at the second procedure).
Results Between January 2014 and January 2015, 127 patients (of 135 we
will enroll) were enrolled at 14 centres: 110 were men and the mean age±SD was
57.1±13.0 years. 98 patients underwent a primary PCI as the first procedure and
29 patients underwent PCI after fibrinolysis. The final TIMI flow at the first pro-
cedure was 3 in 119 patients, 2 in 7 patients, and 1 in 1 patient and the residual
culprit lesion was 61±24%. Glycoprotein IIb/IIIa inhibitor in 42 patients. The
second procedure was performed between 7 and 26 days after the first. None of
the patients died between the two procedures; 1 patient experienced a reocclusion
of the IRA In all cases, initial TIMI flow in the IRA (at the start of the second
procedure) was the same as or better than the final flow after the first procedure.
A stent was implanted in 80 patients, whereas no significant lesion was docu-
mented in 47 patients. Final results will be presented at the meeting.
Conclusions In PCI for acute STEMI, when the thrombus burden is high,
stenting delayed by 7-26 days with intensive antithrombotic cover appears
safe, with only 1 of 130 patients developing an IRA reocclusion.
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Background Between February 2013 and May 2015, of 2,700 coronary
angioplasty procedures realized in our institution, 200 patients aged 65.6 (23-
94) underwent coronary stenting with Absorb Biovascular Scaffold. 
